Genesis Unicorn Capital Corp. currently lacks substantive operating activities. Its central mission is to identify and execute a business combination – which could take the form of a merger, stock exchange, asset acquisition, or other similar transaction – with one or more entities or assets primarily within the biotechnology and pharmaceutical sectors. The firm was established in 2021 and its headquarters are located in Princeton, New Jersey.